Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Bioengineering

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

A Triplex Approach to Bacteria Engineering

Bacteria Engineering

A Triplex Approach to Bacteria Engineering

Emilie Branch

Pharma's Almanac

PAO-M09-19-NI-021September 20, 2019

Tackling Solid Tumors with Engineered Bacteria

Engineered Bacteria

Tackling Solid Tumors with Engineered Bacteria

Emilie Branch

Pharma's Almanac

PAO-M08-19-NI-007August 01, 2019

Harvard Bioengineers' Biomaterial-Based Cancer Immunotherapies to be Developed by Novartis

Immunotherapy

Harvard Bioengineers' Biomaterial-Based Cancer Immunotherapies to be Developed by Novartis

Wyss Institute for Biologically Inspired Engineering at Harvard University

PR-M03-18-NI-082March 23, 2018

Building DNA and RNA Origami for Drug Delivery

Drug Delivery

Building DNA and RNA Origami for Drug Delivery

Nigel Walker

Nice Insight

PAO-M01-18-NI-003January 02, 2018